Carrie (hurwitz) Williams
Partner at McKesson Ventures
Greater Boston
Overview
Work Experience
Partner
2020 - Current
Principal
2017 - 2020
McKesson Ventures is a venture capital firm that invests in early and growth-stage healthcare companies.
VP, Strategy & Business Development
2015 - 2017
Director, Strategy & Business Development
2014 - 2015
Omada Health is a digital behavioral medicine company that helps members change their mindsets to improve health and build lasting change.
Raised $528,520,000.00 from Trousdale Ventures, Wellington Management, Empede Capital, aMoon Fund, Civilization Ventures, Fidelity, Perceptive Advisors and Revelation Partners.
Senior Director, Corporate Strategy & Business Development
2009 - 2014
Advanced from Manager to Director to Sr. Director over the course of my five year tenure. Served as program manager to develop and execute McKesson's enterprise level advanced analytics strategy. Managed a startup venture for a novel clinical trial patient recruitment service delivered through retail pharmacy. Primary responsibilities included business development and sales as well as leading a team responsible for marketing, operations, and client services. Prior experience centered around traditional strategy work with a focus on opportunity identification, research, cross-functional team management, and business case development.
Oncology Program Manager
2006 - 2007
Expanded clinical trial management role to include business development activities as the company explored new clinical indications.
Clinical Trial Manager
2004 - 2006
Managed all elements of a series of clinical trials, including a pivotal Phase 2b study in melanoma that met its primary endpoints to advance to Phase 3. Responsibilities spanned protocol development, site selection, patient recruitment, data management and analysis, site monitoring, and collaboration with and management of CRO partners.
Clinical Trial Manager
2002 - 2004
Managed a range of clinical trial operations activities on behalf of a global metastatic breast cancer program (Phase 2 and Phase 3 studies).
Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.
Raised $32,000,000,000.00 from Starboard Value.